Signaling Pathways - CK1 - DNA-PK - HER2 - MET
清除全部
- B6099 LY3023414Target: Akt|PI3K|mTOR|DNA-PKSummary: I类PI3K,mTOR和DNA-PK抑制剂
- B1438 BMS-794833Target: MET|Flk-1Summary: Met/VEGFR2抑制剂
- B1640 Torin 21 CitationTarget: mTOR|DNA-PK|ATM/ATRSummary: MTOR抑制剂
- B2172 PP121Target: mTOR|Eph Receptors|VEGFR|PDGFR|Bcr-Abl|Src|DNA-PK|P110|HckSummary: 酪氨酸激酶和磷酸肌醇激酶双重抑制剂
- A8649 NU 7026Target: PI3K|DNA-PK|ATMSummary: 有效的、竞争性DNA-PK抑制剂
- A8626 ETP-46464Target: PI3K|mTOR|DNA-PK|ATM/ATRSummary: ATR抑制剂
- A8528 TAK-285Target: EGFR|HER2Summary: HER2/EGFR(HER1)抑制剂
- A8476 MK-2461Target: FLT3|PDGFR|MET|RonSummary: C-Met(野生型/突变型)抑制剂
- A8366 ARRY-380Target: HER2Summary: 酪氨酸激酶HER2和P95-HER2抑制剂。
- A8325 Tivantinib (ARQ 197)2 CitationTarget: METSummary: C-Met抑制剂